324 related articles for article (PubMed ID: 3933340)
1. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
[TBL] [Abstract][Full Text] [Related]
2. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
3. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
4. Stored human platelets retain full aggregation potential in response to pairs of aggregating agents.
DiMinno G; Silver MJ; Murphy S
Blood; 1982 Mar; 59(3):563-8. PubMed ID: 6800418
[No Abstract] [Full Text] [Related]
5. Mechanism of anti-platelet aggregating action of dilazep.
Takenaga M; Kitagawa H; Hirai A; Tamura Y; Yoshida S
J Pharmacobiodyn; 1985 Feb; 8(2):77-83. PubMed ID: 3925115
[TBL] [Abstract][Full Text] [Related]
6. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation.
Rao AK; Koike K; Willis J; Daniel JL; Beckett C; Hassel B; Day HJ; Smith JB; Holmsen H
Blood; 1984 Oct; 64(4):914-21. PubMed ID: 6089937
[TBL] [Abstract][Full Text] [Related]
7. Differences in thromboxane production between neonatal and adult platelets in response to arachidonic acid and epinephrine.
Stuart MJ; Dusse J; Clark DA; Walenga RW
Pediatr Res; 1984 Sep; 18(9):823-6. PubMed ID: 6435080
[TBL] [Abstract][Full Text] [Related]
8. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
Bloom A; Greaves M; Preston FE; Brown CB
Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
[TBL] [Abstract][Full Text] [Related]
9. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
[TBL] [Abstract][Full Text] [Related]
10. Platelet thromboxane synthesis and release reactions in myeloproliferative disorders.
Smith IL; Martin TJ
Haemostasis; 1982; 11(2):119-27. PubMed ID: 6211399
[TBL] [Abstract][Full Text] [Related]
11. Monitoring the entry of new platelets into the circulation after ingestion of aspirin.
Di Minno G; Silver MJ; Murphy S
Blood; 1983 Jun; 61(6):1081-5. PubMed ID: 6404326
[TBL] [Abstract][Full Text] [Related]
12. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Carter AJ; Heptinstall S
Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
[TBL] [Abstract][Full Text] [Related]
13. Interrelation of platelet aggregation, release reaction and thromboxane A2 production.
Balduini CL; Bertolino G; Noris P; Sinigaglia F; Bisio A; Torti M
Biochem Biophys Res Commun; 1988 Oct; 156(2):823-9. PubMed ID: 3190682
[TBL] [Abstract][Full Text] [Related]
14. A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
Fuse I; Hattori A; Higashihara M; Takizawa S; Takeshige T; Hanano M; Nagayama R; Koike T; Takahashi H; Shibata A
Scand J Haematol; 1986 Jan; 36(1):44-54. PubMed ID: 3081995
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
[TBL] [Abstract][Full Text] [Related]
16. Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction.
McDaniel HG; Maddox WT; Poon MC; Rogers WJ; Rackley CE
Am J Cardiol; 1983 Nov; 52(8):965-8. PubMed ID: 6416046
[TBL] [Abstract][Full Text] [Related]
17. Influence of epinephrine on the aggregation response of aspirin-treated platelets.
Rao GH; Johnson GJ; White JG
Prostaglandins Med; 1980 Jul; 5(1):45-58. PubMed ID: 7403340
[TBL] [Abstract][Full Text] [Related]
18. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
19. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
Siess W; Roth P; Weber PC
Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
[TBL] [Abstract][Full Text] [Related]
20. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
